Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/21/20241:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:SOJEThe Southern Company
05/21/20241:00PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPMJP Morgan Chase and Co
05/21/20241:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:SFBSServisFirst Bancshares Inc
05/21/20241:00PMBusiness WireTheory Mortgage Partners with Calque to Offer the Trade-In Mortgage in Oregon
05/21/20241:00PMGlobeNewswire Inc.LaunchDarkly Unveils Software Release Platform for the “Ship at the Speed of Now” Era
05/21/20241:00PMGlobeNewswire Inc.Smart for Life to Attend the 2024 NASC Annual ConferenceNASDAQ:SMFLSmart for Life Inc
05/21/20241:00PMBusiness WireInszone Insurance Services Fortifies Its Chicago Footprint with Strategic Acquisition of ISU Coverall Insurance Group
05/21/20241:00PMPR Newswire (Canada)Négociation des intervenantes en CPE - La FIPEQ-CSQ obtient un mandat de grève à 85 %
05/21/202412:59PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPMJP Morgan Chase and Co
05/21/202412:59PMPR Newswire (Canada)Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA
05/21/202412:59PMPR Newswire (US)Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA
05/21/202412:59PMPR Newswire (US)Cancer Biomarkers Market Size to Grow USD 42170 Million by 2030 at a CAGR of 11.4% | Valuates Reports
05/21/202412:58PMBusiness WireEV Connect und bp pulse kooperieren bei der Bereitstellung von gemeinsamer Flottenmanagement-Lösung
05/21/202412:58PMPR Newswire (US)Duck Donuts® Launches Delicious, Shareable Donut Combinations topped with TWIX®
05/21/202412:57PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPMJP Morgan Chase and Co
05/21/202412:57PMGlobeNewswire Inc.Form 8.5 (EPT/RI) - Touchstone Exploration Inc - AMENDMENT (17/05/2024)
05/21/202412:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TRSTriMas Corporation
05/21/202412:56PMEdgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNYSE:SSTSystem1 Inc
05/21/202412:54PMEdgar (US Regulatory)Form 13F-HR - Quarterly report filed by institutional managers, HoldingsNASDAQ:AROWArrow Financial Corporation
05/21/202412:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASTCAstrotech Corporation
05/21/202412:54PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BNSBank Nova Scotia Halifax
05/21/202412:54PMPR Newswire (US)EnFin Closes Inaugural $253 Million ABS Transaction
05/21/202412:54PMPR Newswire (US)ANDREOZZI + FOOTE FILES LAWSUIT AGAINST UHS DOYLESTOWN, LLC on BEHALF OF ASSAULT SURVIVOR
05/21/202412:53PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:MSMorgan Stanley
05/21/202412:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LEGLeggett and Platt Inc
05/21/202412:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:VELVelocity Financial Inc
05/21/202412:52PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:HSBCHSBC Holdings PLC
05/21/202412:52PMGlobeNewswire Inc.Serve Summer Safe with Food Safety Tips from USDA
05/21/202412:52PMBusiness Wire1Kosmos to Present Session on How to Defeat AI Deepfakes with Live Biometric Authentication at Identiverse 2024
05/21/202412:50PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:MSMorgan Stanley